nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—hematologic cancer—muscle cancer	0.211	0.353	CtDrD
Gemcitabine—urinary bladder cancer—muscle cancer	0.162	0.271	CtDrD
Gemcitabine—kidney cancer—muscle cancer	0.115	0.192	CtDrD
Gemcitabine—lung cancer—muscle cancer	0.11	0.185	CtDrD
Gemcitabine—ABCC10—Vincristine—muscle cancer	0.0622	0.231	CbGbCtD
Gemcitabine—ABCC10—Etoposide—muscle cancer	0.057	0.212	CbGbCtD
Gemcitabine—TYMS—Methotrexate—muscle cancer	0.0457	0.17	CbGbCtD
Gemcitabine—ABCC10—Doxorubicin—muscle cancer	0.0389	0.145	CbGbCtD
Gemcitabine—ABCC10—Methotrexate—muscle cancer	0.0377	0.14	CbGbCtD
Gemcitabine—ABCB1—Dactinomycin—muscle cancer	0.00942	0.035	CbGbCtD
Gemcitabine—ABCB1—Vincristine—muscle cancer	0.0058	0.0215	CbGbCtD
Gemcitabine—ABCB1—Etoposide—muscle cancer	0.00531	0.0197	CbGbCtD
Gemcitabine—ABCB1—Doxorubicin—muscle cancer	0.00362	0.0135	CbGbCtD
Gemcitabine—ABCB1—Methotrexate—muscle cancer	0.00351	0.013	CbGbCtD
Gemcitabine—RRM1—larynx—muscle cancer	0.00313	0.0797	CbGeAlD
Gemcitabine—POLD1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—PMS2—muscle cancer	0.00215	0.11	CbGpPWpGaD
Gemcitabine—POLD1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—PMS2—muscle cancer	0.00215	0.11	CbGpPWpGaD
Gemcitabine—POLD1—MMR—PMS2—muscle cancer	0.00204	0.105	CbGpPWpGaD
Gemcitabine—SLC28A1—renal system—muscle cancer	0.00154	0.0391	CbGeAlD
Gemcitabine—POLD1—renal system—muscle cancer	0.00102	0.0261	CbGeAlD
Gemcitabine—RRM1—E2F transcription factor network—TFE3—muscle cancer	0.00102	0.0523	CbGpPWpGaD
Gemcitabine—POLE—embryo—muscle cancer	0.00101	0.0258	CbGeAlD
Gemcitabine—CMPK1—smooth muscle tissue—muscle cancer	0.000848	0.0216	CbGeAlD
Gemcitabine—RRM2—E2F transcription factor network—TFE3—muscle cancer	0.000838	0.0431	CbGpPWpGaD
Gemcitabine—RRM2—embryo—muscle cancer	0.000833	0.0212	CbGeAlD
Gemcitabine—CMPK1—renal system—muscle cancer	0.000817	0.0208	CbGeAlD
Gemcitabine—SLC29A2—cardiac atrium—muscle cancer	0.000769	0.0196	CbGeAlD
Gemcitabine—CMPK1—cardiac atrium—muscle cancer	0.000731	0.0186	CbGeAlD
Gemcitabine—CDA—tendon—muscle cancer	0.000717	0.0183	CbGeAlD
Gemcitabine—SLC28A3—bone marrow—muscle cancer	0.00071	0.0181	CbGeAlD
Gemcitabine—CDA—bone marrow—muscle cancer	0.000695	0.0177	CbGeAlD
Gemcitabine—RRM1—E2F transcription factor network—TP73—muscle cancer	0.000687	0.0353	CbGpPWpGaD
Gemcitabine—POLD1—head—muscle cancer	0.000685	0.0174	CbGeAlD
Gemcitabine—SLC29A2—tendon—muscle cancer	0.00067	0.0171	CbGeAlD
Gemcitabine—CDA—vagina—muscle cancer	0.000665	0.0169	CbGeAlD
Gemcitabine—POLD1—testis—muscle cancer	0.000662	0.0169	CbGeAlD
Gemcitabine—RRM2—renal system—muscle cancer	0.00063	0.0161	CbGeAlD
Gemcitabine—SLC29A2—vagina—muscle cancer	0.000622	0.0158	CbGeAlD
Gemcitabine—CMPK1—bone marrow—muscle cancer	0.000617	0.0157	CbGeAlD
Gemcitabine—POLE—tendon—muscle cancer	0.000597	0.0152	CbGeAlD
Gemcitabine—RRM2—Vinorelbine—Vincristine—muscle cancer	0.000597	0.297	CbGdCrCtD
Gemcitabine—CDA—testis—muscle cancer	0.000594	0.0151	CbGeAlD
Gemcitabine—CMPK1—vagina—muscle cancer	0.000592	0.0151	CbGeAlD
Gemcitabine—POLE—bone marrow—muscle cancer	0.000579	0.0147	CbGeAlD
Gemcitabine—POLA1—E2F transcription factor network—TFE3—muscle cancer	0.000573	0.0295	CbGpPWpGaD
Gemcitabine—RRM2—E2F transcription factor network—TP73—muscle cancer	0.000566	0.0291	CbGpPWpGaD
Gemcitabine—POLA1—Vinblastine—Vincristine—muscle cancer	0.000565	0.281	CbGdCrCtD
Gemcitabine—POLE—vagina—muscle cancer	0.000554	0.0141	CbGeAlD
Gemcitabine—TYMS—E2F transcription factor network—TFE3—muscle cancer	0.000549	0.0282	CbGpPWpGaD
Gemcitabine—CMPK1—head—muscle cancer	0.000546	0.0139	CbGeAlD
Gemcitabine—RRM1—smooth muscle tissue—muscle cancer	0.000544	0.0139	CbGeAlD
Gemcitabine—DCK—embryo—muscle cancer	0.000537	0.0137	CbGeAlD
Gemcitabine—CMPK1—testis—muscle cancer	0.000528	0.0134	CbGeAlD
Gemcitabine—RRM1—renal system—muscle cancer	0.000524	0.0133	CbGeAlD
Gemcitabine—POLA1—tendon—muscle cancer	0.000515	0.0131	CbGeAlD
Gemcitabine—POLE—head—muscle cancer	0.000512	0.013	CbGeAlD
Gemcitabine—POLA1—bone marrow—muscle cancer	0.000499	0.0127	CbGeAlD
Gemcitabine—POLE—testis—muscle cancer	0.000495	0.0126	CbGeAlD
Gemcitabine—TYMS—smooth muscle tissue—muscle cancer	0.000493	0.0126	CbGeAlD
Gemcitabine—RRM2—tendon—muscle cancer	0.000492	0.0125	CbGeAlD
Gemcitabine—POLA1—vagina—muscle cancer	0.000478	0.0122	CbGeAlD
Gemcitabine—RRM2—bone marrow—muscle cancer	0.000476	0.0121	CbGeAlD
Gemcitabine—RRM1—cardiac atrium—muscle cancer	0.000469	0.0119	CbGeAlD
Gemcitabine—RRM2—vagina—muscle cancer	0.000456	0.0116	CbGeAlD
Gemcitabine—POLD1—DNA Repair—PMS2—muscle cancer	0.000427	0.0219	CbGpPWpGaD
Gemcitabine—POLA1—testis—muscle cancer	0.000426	0.0109	CbGeAlD
Gemcitabine—SLC29A1—renal system—muscle cancer	0.000426	0.0108	CbGeAlD
Gemcitabine—RRM2—head—muscle cancer	0.000422	0.0107	CbGeAlD
Gemcitabine—POLE—DNA Repair—PMS2—muscle cancer	0.000412	0.0212	CbGpPWpGaD
Gemcitabine—RRM1—tendon—muscle cancer	0.000409	0.0104	CbGeAlD
Gemcitabine—RRM2—testis—muscle cancer	0.000407	0.0104	CbGeAlD
Gemcitabine—RRM1—bone marrow—muscle cancer	0.000396	0.0101	CbGeAlD
Gemcitabine—ABCC10—renal system—muscle cancer	0.000387	0.00987	CbGeAlD
Gemcitabine—POLA1—E2F transcription factor network—TP73—muscle cancer	0.000387	0.0199	CbGpPWpGaD
Gemcitabine—SLC29A1—cardiac atrium—muscle cancer	0.000381	0.00971	CbGeAlD
Gemcitabine—RRM1—vagina—muscle cancer	0.000379	0.00966	CbGeAlD
Gemcitabine—TYMS—E2F transcription factor network—TP73—muscle cancer	0.000371	0.0191	CbGpPWpGaD
Gemcitabine—TYMS—tendon—muscle cancer	0.000371	0.00944	CbGeAlD
Gemcitabine—DCK—cardiac atrium—muscle cancer	0.000364	0.00928	CbGeAlD
Gemcitabine—TYMS—bone marrow—muscle cancer	0.000359	0.00914	CbGeAlD
Gemcitabine—RRM1—head—muscle cancer	0.00035	0.00892	CbGeAlD
Gemcitabine—ABCC10—cardiac atrium—muscle cancer	0.000347	0.00884	CbGeAlD
Gemcitabine—TYMS—vagina—muscle cancer	0.000344	0.00876	CbGeAlD
Gemcitabine—RRM1—testis—muscle cancer	0.000338	0.00862	CbGeAlD
Gemcitabine—SLC29A1—tendon—muscle cancer	0.000332	0.00846	CbGeAlD
Gemcitabine—SLC29A1—bone marrow—muscle cancer	0.000322	0.0082	CbGeAlD
Gemcitabine—TYMS—head—muscle cancer	0.000318	0.00809	CbGeAlD
Gemcitabine—DCK—tendon—muscle cancer	0.000317	0.00809	CbGeAlD
Gemcitabine—SLC29A1—vagina—muscle cancer	0.000308	0.00785	CbGeAlD
Gemcitabine—DCK—bone marrow—muscle cancer	0.000307	0.00783	CbGeAlD
Gemcitabine—TYMS—testis—muscle cancer	0.000307	0.00782	CbGeAlD
Gemcitabine—ABCC10—tendon—muscle cancer	0.000302	0.0077	CbGeAlD
Gemcitabine—DCK—vagina—muscle cancer	0.000295	0.0075	CbGeAlD
Gemcitabine—ABCC10—bone marrow—muscle cancer	0.000293	0.00746	CbGeAlD
Gemcitabine—SLC29A1—head—muscle cancer	0.000285	0.00725	CbGeAlD
Gemcitabine—ABCC10—vagina—muscle cancer	0.000281	0.00715	CbGeAlD
Gemcitabine—SLC29A1—testis—muscle cancer	0.000275	0.00701	CbGeAlD
Gemcitabine—DCK—head—muscle cancer	0.000272	0.00693	CbGeAlD
Gemcitabine—DCK—testis—muscle cancer	0.000263	0.00669	CbGeAlD
Gemcitabine—TYMS—Vinorelbine—Vincristine—muscle cancer	0.000255	0.127	CbGdCrCtD
Gemcitabine—TYMS—Podofilox—Etoposide—muscle cancer	0.000255	0.127	CbGdCrCtD
Gemcitabine—ABCC10—testis—muscle cancer	0.00025	0.00638	CbGeAlD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000241	0.0124	CbGpPWpGaD
Gemcitabine—CDA—Fluoropyrimidine Activity—TP53—muscle cancer	0.000241	0.0124	CbGpPWpGaD
Gemcitabine—RRM1—Fluoropyrimidine Activity—TP53—muscle cancer	0.000183	0.0094	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000176	0.00907	CbGpPWpGaD
Gemcitabine—TYMS—Vinblastine—Vincristine—muscle cancer	0.000175	0.0872	CbGdCrCtD
Gemcitabine—RRM1—E2F transcription factor network—CDKN2A—muscle cancer	0.000174	0.00895	CbGpPWpGaD
Gemcitabine—SLC29A1—Fluoropyrimidine Activity—TP53—muscle cancer	0.000167	0.00859	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—FH—muscle cancer	0.000167	0.00858	CbGpPWpGaD
Gemcitabine—DCK—Epirubicin—Doxorubicin—muscle cancer	0.000163	0.0812	CbGdCrCtD
Gemcitabine—RRM2—Fluoropyrimidine Activity—TP53—muscle cancer	0.000151	0.00774	CbGpPWpGaD
Gemcitabine—ABCB1—embryo—muscle cancer	0.000148	0.00376	CbGeAlD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—MDM2—muscle cancer	0.000147	0.00754	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—CDKN2A—muscle cancer	0.000146	0.00748	CbGpPWpGaD
Gemcitabine—RRM2—E2F transcription factor network—CDKN2A—muscle cancer	0.000143	0.00737	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—MDM2—muscle cancer	0.000141	0.00726	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000136	0.00699	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.00013	0.00669	CbGpPWpGaD
Gemcitabine—Injection site reaction—Doxorubicin—muscle cancer	0.000124	0.0017	CcSEcCtD
Gemcitabine—Myalgia—Dactinomycin—muscle cancer	0.000123	0.00169	CcSEcCtD
Gemcitabine—Discomfort—Dactinomycin—muscle cancer	0.000122	0.00167	CcSEcCtD
Gemcitabine—Influenza like illness—Doxorubicin—muscle cancer	0.000121	0.00166	CcSEcCtD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—MDM2—muscle cancer	0.000121	0.00621	CbGpPWpGaD
Gemcitabine—Anaemia—Vincristine—muscle cancer	0.00012	0.00164	CcSEcCtD
Gemcitabine—Urinary tract disorder—Etoposide—muscle cancer	0.000119	0.00163	CcSEcCtD
Gemcitabine—Skin exfoliation—Doxorubicin—muscle cancer	0.000119	0.00163	CcSEcCtD
Gemcitabine—Oedema—Dactinomycin—muscle cancer	0.000118	0.00162	CcSEcCtD
Gemcitabine—Fluid retention—Doxorubicin—muscle cancer	0.000118	0.00162	CcSEcCtD
Gemcitabine—Urethral disorder—Etoposide—muscle cancer	0.000118	0.00162	CcSEcCtD
Gemcitabine—Infection—Dactinomycin—muscle cancer	0.000118	0.00161	CcSEcCtD
Gemcitabine—Blood urea increased—Doxorubicin—muscle cancer	0.000118	0.00161	CcSEcCtD
Gemcitabine—Neuropathy—Doxorubicin—muscle cancer	0.000117	0.0016	CcSEcCtD
Gemcitabine—Hepatic failure—Methotrexate—muscle cancer	0.000116	0.00159	CcSEcCtD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—MDM2—muscle cancer	0.000116	0.00596	CbGpPWpGaD
Gemcitabine—Leukopenia—Vincristine—muscle cancer	0.000116	0.00159	CcSEcCtD
Gemcitabine—Thrombocytopenia—Dactinomycin—muscle cancer	0.000116	0.00159	CcSEcCtD
Gemcitabine—Erythema multiforme—Etoposide—muscle cancer	0.000114	0.00156	CcSEcCtD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—MDM2—muscle cancer	0.000113	0.0058	CbGpPWpGaD
Gemcitabine—Anorexia—Dactinomycin—muscle cancer	0.000113	0.00155	CcSEcCtD
Gemcitabine—Cardiac disorder—Etoposide—muscle cancer	0.000112	0.00153	CcSEcCtD
Gemcitabine—ABCB1—renal system—muscle cancer	0.000112	0.00285	CbGeAlD
Gemcitabine—Hypertension—Vincristine—muscle cancer	0.000112	0.00153	CcSEcCtD
Gemcitabine—Pulmonary oedema—Doxorubicin—muscle cancer	0.000111	0.00152	CcSEcCtD
Gemcitabine—Myalgia—Vincristine—muscle cancer	0.00011	0.00151	CcSEcCtD
Gemcitabine—Angiopathy—Etoposide—muscle cancer	0.000109	0.0015	CcSEcCtD
Gemcitabine—Immune system disorder—Etoposide—muscle cancer	0.000109	0.00149	CcSEcCtD
Gemcitabine—Mediastinal disorder—Etoposide—muscle cancer	0.000109	0.00149	CcSEcCtD
Gemcitabine—Chills—Etoposide—muscle cancer	0.000108	0.00148	CcSEcCtD
Gemcitabine—Sepsis—Doxorubicin—muscle cancer	0.000108	0.00148	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000108	0.00148	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000108	0.00148	CcSEcCtD
Gemcitabine—Alopecia—Etoposide—muscle cancer	0.000107	0.00146	CcSEcCtD
Gemcitabine—Cerebrovascular accident—Methotrexate—muscle cancer	0.000107	0.00146	CcSEcCtD
Gemcitabine—Oedema—Vincristine—muscle cancer	0.000106	0.00145	CcSEcCtD
Gemcitabine—Anaphylactic shock—Vincristine—muscle cancer	0.000106	0.00145	CcSEcCtD
Gemcitabine—Infection—Vincristine—muscle cancer	0.000105	0.00144	CcSEcCtD
Gemcitabine—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.000104	0.00142	CcSEcCtD
Gemcitabine—Nervous system disorder—Vincristine—muscle cancer	0.000104	0.00142	CcSEcCtD
Gemcitabine—Thrombocytopenia—Vincristine—muscle cancer	0.000104	0.00142	CcSEcCtD
Gemcitabine—Hepatic function abnormal—Doxorubicin—muscle cancer	0.000103	0.00142	CcSEcCtD
Gemcitabine—CDA—Metabolism—FH—muscle cancer	0.000103	0.0053	CbGpPWpGaD
Gemcitabine—Decreased appetite—Dactinomycin—muscle cancer	0.000103	0.00141	CcSEcCtD
Gemcitabine—Hyperhidrosis—Vincristine—muscle cancer	0.000102	0.0014	CcSEcCtD
Gemcitabine—Fatigue—Dactinomycin—muscle cancer	0.000102	0.0014	CcSEcCtD
Gemcitabine—Back pain—Etoposide—muscle cancer	0.000102	0.00139	CcSEcCtD
Gemcitabine—Pain—Dactinomycin—muscle cancer	0.000101	0.00139	CcSEcCtD
Gemcitabine—Anorexia—Vincristine—muscle cancer	0.000101	0.00138	CcSEcCtD
Gemcitabine—Hepatic failure—Doxorubicin—muscle cancer	0.000101	0.00138	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Doxorubicin—muscle cancer	9.97e-05	0.00137	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	9.94e-05	0.00511	CbGpPWpGaD
Gemcitabine—Hypotension—Vincristine—muscle cancer	9.88e-05	0.00135	CcSEcCtD
Gemcitabine—TYMS—Fluoropyrimidine Activity—TP53—muscle cancer	9.87e-05	0.00507	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—CDKN2A—muscle cancer	9.8e-05	0.00504	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Dactinomycin—muscle cancer	9.75e-05	0.00134	CcSEcCtD
Gemcitabine—Ill-defined disorder—Etoposide—muscle cancer	9.74e-05	0.00134	CcSEcCtD
Gemcitabine—Anaemia—Etoposide—muscle cancer	9.7e-05	0.00133	CcSEcCtD
Gemcitabine—Liver function test abnormal—Methotrexate—muscle cancer	9.64e-05	0.00132	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Vincristine—muscle cancer	9.63e-05	0.00132	CcSEcCtD
Gemcitabine—Insomnia—Vincristine—muscle cancer	9.56e-05	0.00131	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	9.52e-05	0.00489	CbGpPWpGaD
Gemcitabine—Renal impairment—Doxorubicin—muscle cancer	9.5e-05	0.0013	CcSEcCtD
Gemcitabine—Paraesthesia—Vincristine—muscle cancer	9.49e-05	0.0013	CcSEcCtD
Gemcitabine—Malaise—Etoposide—muscle cancer	9.46e-05	0.0013	CcSEcCtD
Gemcitabine—Dermatitis bullous—Doxorubicin—muscle cancer	9.46e-05	0.0013	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—MED12—muscle cancer	9.43e-05	0.00485	CbGpPWpGaD
Gemcitabine—Toxic epidermal necrolysis—Methotrexate—muscle cancer	9.4e-05	0.00129	CcSEcCtD
Gemcitabine—Leukopenia—Etoposide—muscle cancer	9.39e-05	0.00129	CcSEcCtD
Gemcitabine—TYMS—E2F transcription factor network—CDKN2A—muscle cancer	9.39e-05	0.00483	CbGpPWpGaD
Gemcitabine—Body temperature increased—Dactinomycin—muscle cancer	9.36e-05	0.00128	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Doxorubicin—muscle cancer	9.34e-05	0.00128	CcSEcCtD
Gemcitabine—Cardiac failure—Doxorubicin—muscle cancer	9.26e-05	0.00127	CcSEcCtD
Gemcitabine—Cerebrovascular accident—Doxorubicin—muscle cancer	9.22e-05	0.00126	CcSEcCtD
Gemcitabine—Decreased appetite—Vincristine—muscle cancer	9.19e-05	0.00126	CcSEcCtD
Gemcitabine—Cough—Etoposide—muscle cancer	9.16e-05	0.00126	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Vincristine—muscle cancer	9.13e-05	0.00125	CcSEcCtD
Gemcitabine—Fatigue—Vincristine—muscle cancer	9.12e-05	0.00125	CcSEcCtD
Gemcitabine—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	9.06e-05	0.00466	CbGpPWpGaD
Gemcitabine—Hypertension—Etoposide—muscle cancer	9.06e-05	0.00124	CcSEcCtD
Gemcitabine—Constipation—Vincristine—muscle cancer	9.04e-05	0.00124	CcSEcCtD
Gemcitabine—Pain—Vincristine—muscle cancer	9.04e-05	0.00124	CcSEcCtD
Gemcitabine—POLE—Mitotic M-M/G1 phases—BUB1B—muscle cancer	9.03e-05	0.00464	CbGpPWpGaD
Gemcitabine—Chest pain—Etoposide—muscle cancer	8.94e-05	0.00123	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	8.87e-05	0.00122	CcSEcCtD
Gemcitabine—Discomfort—Etoposide—muscle cancer	8.83e-05	0.00121	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CDKN2A—muscle cancer	8.77e-05	0.0045	CbGpPWpGaD
Gemcitabine—Face oedema—Doxorubicin—muscle cancer	8.73e-05	0.0012	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—ENO2—muscle cancer	8.6e-05	0.00442	CbGpPWpGaD
Gemcitabine—Pancytopenia—Methotrexate—muscle cancer	8.57e-05	0.00117	CcSEcCtD
Gemcitabine—Anaphylactic shock—Etoposide—muscle cancer	8.57e-05	0.00117	CcSEcCtD
Gemcitabine—Infection—Etoposide—muscle cancer	8.51e-05	0.00117	CcSEcCtD
Gemcitabine—Asthenia—Dactinomycin—muscle cancer	8.49e-05	0.00116	CcSEcCtD
Gemcitabine—Blood creatinine increased—Doxorubicin—muscle cancer	8.47e-05	0.00116	CcSEcCtD
Gemcitabine—ABCB1—bone marrow—muscle cancer	8.46e-05	0.00215	CbGeAlD
Gemcitabine—Neutropenia—Methotrexate—muscle cancer	8.44e-05	0.00116	CcSEcCtD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	8.42e-05	0.00433	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CDKN2A—muscle cancer	8.41e-05	0.00432	CbGpPWpGaD
Gemcitabine—Thrombocytopenia—Etoposide—muscle cancer	8.39e-05	0.00115	CcSEcCtD
Gemcitabine—Body temperature increased—Vincristine—muscle cancer	8.36e-05	0.00115	CcSEcCtD
Gemcitabine—Liver function test abnormal—Doxorubicin—muscle cancer	8.35e-05	0.00114	CcSEcCtD
Gemcitabine—Skin disorder—Etoposide—muscle cancer	8.32e-05	0.00114	CcSEcCtD
Gemcitabine—Hyperhidrosis—Etoposide—muscle cancer	8.28e-05	0.00114	CcSEcCtD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—muscle cancer	8.26e-05	0.00425	CbGpPWpGaD
Gemcitabine—Hypokalaemia—Doxorubicin—muscle cancer	8.23e-05	0.00113	CcSEcCtD
Gemcitabine—Anorexia—Etoposide—muscle cancer	8.16e-05	0.00112	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	8.14e-05	0.00112	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	8.14e-05	0.00112	CcSEcCtD
Gemcitabine—POLE—G1 to S cell cycle control—TP53—muscle cancer	8.1e-05	0.00417	CbGpPWpGaD
Gemcitabine—ABCB1—vagina—muscle cancer	8.1e-05	0.00206	CbGeAlD
Gemcitabine—Diarrhoea—Dactinomycin—muscle cancer	8.1e-05	0.00111	CcSEcCtD
Gemcitabine—Pneumonia—Methotrexate—muscle cancer	8.09e-05	0.00111	CcSEcCtD
Gemcitabine—Hypotension—Etoposide—muscle cancer	8e-05	0.0011	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	7.98e-05	0.00109	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	7.97e-05	0.00109	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—MDM2—muscle cancer	7.92e-05	0.00407	CbGpPWpGaD
Gemcitabine—Renal failure—Methotrexate—muscle cancer	7.91e-05	0.00108	CcSEcCtD
Gemcitabine—Stomatitis—Methotrexate—muscle cancer	7.84e-05	0.00108	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	7.82e-05	0.00402	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—FH—muscle cancer	7.82e-05	0.00402	CbGpPWpGaD
Gemcitabine—Influenza—Doxorubicin—muscle cancer	7.81e-05	0.00107	CcSEcCtD
Gemcitabine—Sweating—Methotrexate—muscle cancer	7.71e-05	0.00106	CcSEcCtD
Gemcitabine—Paraesthesia—Etoposide—muscle cancer	7.69e-05	0.00105	CcSEcCtD
Gemcitabine—Haematuria—Methotrexate—muscle cancer	7.67e-05	0.00105	CcSEcCtD
Gemcitabine—Dyspnoea—Etoposide—muscle cancer	7.64e-05	0.00105	CcSEcCtD
Gemcitabine—Somnolence—Etoposide—muscle cancer	7.61e-05	0.00104	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Methotrexate—muscle cancer	7.61e-05	0.00104	CcSEcCtD
Gemcitabine—Asthenia—Vincristine—muscle cancer	7.59e-05	0.00104	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	7.54e-05	0.00387	CbGpPWpGaD
Gemcitabine—Vomiting—Dactinomycin—muscle cancer	7.52e-05	0.00103	CcSEcCtD
Gemcitabine—Agranulocytosis—Methotrexate—muscle cancer	7.51e-05	0.00103	CcSEcCtD
Gemcitabine—ABCB1—head—muscle cancer	7.48e-05	0.00191	CbGeAlD
Gemcitabine—Rash—Dactinomycin—muscle cancer	7.46e-05	0.00102	CcSEcCtD
Gemcitabine—Decreased appetite—Etoposide—muscle cancer	7.45e-05	0.00102	CcSEcCtD
Gemcitabine—Pancytopenia—Doxorubicin—muscle cancer	7.42e-05	0.00102	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Etoposide—muscle cancer	7.39e-05	0.00101	CcSEcCtD
Gemcitabine—Fatigue—Etoposide—muscle cancer	7.38e-05	0.00101	CcSEcCtD
Gemcitabine—Pain—Etoposide—muscle cancer	7.32e-05	0.001	CcSEcCtD
Gemcitabine—Constipation—Etoposide—muscle cancer	7.32e-05	0.001	CcSEcCtD
Gemcitabine—Neutropenia—Doxorubicin—muscle cancer	7.31e-05	0.001	CcSEcCtD
Gemcitabine—Haemoglobin—Methotrexate—muscle cancer	7.26e-05	0.000995	CcSEcCtD
Gemcitabine—Diarrhoea—Vincristine—muscle cancer	7.23e-05	0.000992	CcSEcCtD
Gemcitabine—ABCB1—testis—muscle cancer	7.23e-05	0.00184	CbGeAlD
Gemcitabine—Haemorrhage—Methotrexate—muscle cancer	7.22e-05	0.00099	CcSEcCtD
Gemcitabine—Pharyngitis—Methotrexate—muscle cancer	7.17e-05	0.000983	CcSEcCtD
Gemcitabine—Urinary tract disorder—Methotrexate—muscle cancer	7.13e-05	0.000978	CcSEcCtD
Gemcitabine—Urethral disorder—Methotrexate—muscle cancer	7.08e-05	0.000971	CcSEcCtD
Gemcitabine—Feeling abnormal—Etoposide—muscle cancer	7.06e-05	0.000968	CcSEcCtD
Gemcitabine—Hyperglycaemia—Doxorubicin—muscle cancer	7.05e-05	0.000966	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—BUB1B—muscle cancer	7.04e-05	0.00362	CbGpPWpGaD
Gemcitabine—Nausea—Dactinomycin—muscle cancer	7.03e-05	0.000964	CcSEcCtD
Gemcitabine—Pneumonia—Doxorubicin—muscle cancer	7.01e-05	0.000961	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle, Mitotic—BUB1B—muscle cancer	6.99e-05	0.00359	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	6.93e-05	0.00356	CbGpPWpGaD
Gemcitabine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	6.91e-05	0.000947	CcSEcCtD
Gemcitabine—Renal failure—Doxorubicin—muscle cancer	6.85e-05	0.000939	CcSEcCtD
Gemcitabine—Erythema multiforme—Methotrexate—muscle cancer	6.83e-05	0.000936	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Doxorubicin—muscle cancer	6.83e-05	0.000936	CcSEcCtD
Gemcitabine—Stomatitis—Doxorubicin—muscle cancer	6.79e-05	0.000931	CcSEcCtD
Gemcitabine—Body temperature increased—Etoposide—muscle cancer	6.77e-05	0.000928	CcSEcCtD
Gemcitabine—POLE—Cell Cycle, Mitotic—BUB1B—muscle cancer	6.75e-05	0.00347	CbGpPWpGaD
Gemcitabine—Vomiting—Vincristine—muscle cancer	6.72e-05	0.000922	CcSEcCtD
Gemcitabine—Cardiac disorder—Methotrexate—muscle cancer	6.7e-05	0.000919	CcSEcCtD
Gemcitabine—Sweating—Doxorubicin—muscle cancer	6.68e-05	0.000916	CcSEcCtD
Gemcitabine—Rash—Vincristine—muscle cancer	6.67e-05	0.000914	CcSEcCtD
Gemcitabine—Dermatitis—Vincristine—muscle cancer	6.66e-05	0.000913	CcSEcCtD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	6.65e-05	0.00342	CbGpPWpGaD
Gemcitabine—Haematuria—Doxorubicin—muscle cancer	6.64e-05	0.000911	CcSEcCtD
Gemcitabine—Headache—Vincristine—muscle cancer	6.62e-05	0.000908	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Doxorubicin—muscle cancer	6.59e-05	0.000903	CcSEcCtD
Gemcitabine—Angiopathy—Methotrexate—muscle cancer	6.55e-05	0.000898	CcSEcCtD
Gemcitabine—Immune system disorder—Methotrexate—muscle cancer	6.52e-05	0.000894	CcSEcCtD
Gemcitabine—Mediastinal disorder—Methotrexate—muscle cancer	6.51e-05	0.000892	CcSEcCtD
Gemcitabine—Agranulocytosis—Doxorubicin—muscle cancer	6.5e-05	0.000891	CcSEcCtD
Gemcitabine—Chills—Methotrexate—muscle cancer	6.48e-05	0.000888	CcSEcCtD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	6.48e-05	0.00333	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—FH—muscle cancer	6.44e-05	0.00331	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—BUB1B—muscle cancer	6.43e-05	0.00331	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—FH—muscle cancer	6.4e-05	0.00329	CbGpPWpGaD
Gemcitabine—Alopecia—Methotrexate—muscle cancer	6.38e-05	0.000875	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—BUB1B—muscle cancer	6.29e-05	0.00323	CbGpPWpGaD
Gemcitabine—Erythema—Methotrexate—muscle cancer	6.29e-05	0.000862	CcSEcCtD
Gemcitabine—Haemoglobin—Doxorubicin—muscle cancer	6.28e-05	0.000862	CcSEcCtD
Gemcitabine—Nausea—Vincristine—muscle cancer	6.28e-05	0.000861	CcSEcCtD
Gemcitabine—Rhinitis—Doxorubicin—muscle cancer	6.27e-05	0.00086	CcSEcCtD
Gemcitabine—Haemorrhage—Doxorubicin—muscle cancer	6.25e-05	0.000857	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—BUB1B—muscle cancer	6.25e-05	0.00321	CbGpPWpGaD
Gemcitabine—Pharyngitis—Doxorubicin—muscle cancer	6.21e-05	0.000851	CcSEcCtD
Gemcitabine—Urinary tract disorder—Doxorubicin—muscle cancer	6.18e-05	0.000847	CcSEcCtD
Gemcitabine—Oedema peripheral—Doxorubicin—muscle cancer	6.16e-05	0.000845	CcSEcCtD
Gemcitabine—Asthenia—Etoposide—muscle cancer	6.15e-05	0.000843	CcSEcCtD
Gemcitabine—Connective tissue disorder—Doxorubicin—muscle cancer	6.14e-05	0.000843	CcSEcCtD
Gemcitabine—Urethral disorder—Doxorubicin—muscle cancer	6.13e-05	0.00084	CcSEcCtD
Gemcitabine—Back pain—Methotrexate—muscle cancer	6.08e-05	0.000834	CcSEcCtD
Gemcitabine—Pruritus—Etoposide—muscle cancer	6.06e-05	0.000831	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—BUB1B—muscle cancer	6.04e-05	0.0031	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—FH—muscle cancer	6.01e-05	0.00309	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—muscle cancer	6e-05	0.00308	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	5.94e-05	0.00305	CbGpPWpGaD
Gemcitabine—Erythema multiforme—Doxorubicin—muscle cancer	5.91e-05	0.000811	CcSEcCtD
Gemcitabine—Diarrhoea—Etoposide—muscle cancer	5.86e-05	0.000804	CcSEcCtD
Gemcitabine—Ill-defined disorder—Methotrexate—muscle cancer	5.83e-05	0.0008	CcSEcCtD
Gemcitabine—CDA—Metabolism—MED12—muscle cancer	5.83e-05	0.00299	CbGpPWpGaD
Gemcitabine—Anaemia—Methotrexate—muscle cancer	5.81e-05	0.000797	CcSEcCtD
Gemcitabine—Cardiac disorder—Doxorubicin—muscle cancer	5.8e-05	0.000796	CcSEcCtD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—muscle cancer	5.74e-05	0.00295	CbGpPWpGaD
Gemcitabine—Angiopathy—Doxorubicin—muscle cancer	5.67e-05	0.000778	CcSEcCtD
Gemcitabine—Malaise—Methotrexate—muscle cancer	5.67e-05	0.000777	CcSEcCtD
Gemcitabine—Immune system disorder—Doxorubicin—muscle cancer	5.65e-05	0.000774	CcSEcCtD
Gemcitabine—Mediastinal disorder—Doxorubicin—muscle cancer	5.64e-05	0.000773	CcSEcCtD
Gemcitabine—Leukopenia—Methotrexate—muscle cancer	5.63e-05	0.000772	CcSEcCtD
Gemcitabine—Chills—Doxorubicin—muscle cancer	5.61e-05	0.000769	CcSEcCtD
Gemcitabine—Arrhythmia—Doxorubicin—muscle cancer	5.59e-05	0.000766	CcSEcCtD
Gemcitabine—Alopecia—Doxorubicin—muscle cancer	5.53e-05	0.000758	CcSEcCtD
Gemcitabine—Cough—Methotrexate—muscle cancer	5.49e-05	0.000752	CcSEcCtD
Gemcitabine—Vomiting—Etoposide—muscle cancer	5.45e-05	0.000747	CcSEcCtD
Gemcitabine—Erythema—Doxorubicin—muscle cancer	5.44e-05	0.000746	CcSEcCtD
Gemcitabine—Rash—Etoposide—muscle cancer	5.4e-05	0.000741	CcSEcCtD
Gemcitabine—Dermatitis—Etoposide—muscle cancer	5.4e-05	0.00074	CcSEcCtD
Gemcitabine—Headache—Etoposide—muscle cancer	5.37e-05	0.000736	CcSEcCtD
Gemcitabine—Chest pain—Methotrexate—muscle cancer	5.35e-05	0.000734	CcSEcCtD
Gemcitabine—Arthralgia—Methotrexate—muscle cancer	5.35e-05	0.000734	CcSEcCtD
Gemcitabine—Myalgia—Methotrexate—muscle cancer	5.35e-05	0.000734	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	5.32e-05	0.000729	CcSEcCtD
Gemcitabine—CDA—Metabolism—ENO2—muscle cancer	5.31e-05	0.00273	CbGpPWpGaD
Gemcitabine—Discomfort—Methotrexate—muscle cancer	5.29e-05	0.000725	CcSEcCtD
Gemcitabine—Back pain—Doxorubicin—muscle cancer	5.27e-05	0.000722	CcSEcCtD
Gemcitabine—Anaphylactic shock—Methotrexate—muscle cancer	5.13e-05	0.000703	CcSEcCtD
Gemcitabine—Infection—Methotrexate—muscle cancer	5.1e-05	0.000699	CcSEcCtD
Gemcitabine—Nausea—Etoposide—muscle cancer	5.09e-05	0.000698	CcSEcCtD
Gemcitabine—Ill-defined disorder—Doxorubicin—muscle cancer	5.05e-05	0.000693	CcSEcCtD
Gemcitabine—Nervous system disorder—Methotrexate—muscle cancer	5.03e-05	0.00069	CcSEcCtD
Gemcitabine—Anaemia—Doxorubicin—muscle cancer	5.03e-05	0.00069	CcSEcCtD
Gemcitabine—Thrombocytopenia—Methotrexate—muscle cancer	5.02e-05	0.000689	CcSEcCtD
Gemcitabine—Skin disorder—Methotrexate—muscle cancer	4.98e-05	0.000683	CcSEcCtD
Gemcitabine—Hyperhidrosis—Methotrexate—muscle cancer	4.96e-05	0.00068	CcSEcCtD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	4.91e-05	0.00252	CbGpPWpGaD
Gemcitabine—Malaise—Doxorubicin—muscle cancer	4.91e-05	0.000673	CcSEcCtD
Gemcitabine—Anorexia—Methotrexate—muscle cancer	4.89e-05	0.000671	CcSEcCtD
Gemcitabine—Leukopenia—Doxorubicin—muscle cancer	4.87e-05	0.000668	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—BUB1B—muscle cancer	4.81e-05	0.00247	CbGpPWpGaD
Gemcitabine—Hypotension—Methotrexate—muscle cancer	4.79e-05	0.000657	CcSEcCtD
Gemcitabine—Cough—Doxorubicin—muscle cancer	4.75e-05	0.000651	CcSEcCtD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	4.74e-05	0.00244	CbGpPWpGaD
Gemcitabine—Hypertension—Doxorubicin—muscle cancer	4.7e-05	0.000644	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Methotrexate—muscle cancer	4.67e-05	0.000641	CcSEcCtD
Gemcitabine—Insomnia—Methotrexate—muscle cancer	4.64e-05	0.000636	CcSEcCtD
Gemcitabine—Arthralgia—Doxorubicin—muscle cancer	4.63e-05	0.000635	CcSEcCtD
Gemcitabine—Chest pain—Doxorubicin—muscle cancer	4.63e-05	0.000635	CcSEcCtD
Gemcitabine—Myalgia—Doxorubicin—muscle cancer	4.63e-05	0.000635	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—BUB1B—muscle cancer	4.61e-05	0.00237	CbGpPWpGaD
Gemcitabine—Paraesthesia—Methotrexate—muscle cancer	4.61e-05	0.000632	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	4.6e-05	0.000631	CcSEcCtD
Gemcitabine—Discomfort—Doxorubicin—muscle cancer	4.58e-05	0.000628	CcSEcCtD
Gemcitabine—Dyspnoea—Methotrexate—muscle cancer	4.57e-05	0.000627	CcSEcCtD
Gemcitabine—Somnolence—Methotrexate—muscle cancer	4.56e-05	0.000625	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	4.54e-05	0.00233	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	4.49e-05	0.00231	CbGpPWpGaD
Gemcitabine—Decreased appetite—Methotrexate—muscle cancer	4.46e-05	0.000612	CcSEcCtD
Gemcitabine—Anaphylactic shock—Doxorubicin—muscle cancer	4.44e-05	0.000609	CcSEcCtD
Gemcitabine—Oedema—Doxorubicin—muscle cancer	4.44e-05	0.000609	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Methotrexate—muscle cancer	4.43e-05	0.000607	CcSEcCtD
Gemcitabine—Fatigue—Methotrexate—muscle cancer	4.42e-05	0.000607	CcSEcCtD
Gemcitabine—RRM1—Metabolism—MED12—muscle cancer	4.42e-05	0.00227	CbGpPWpGaD
Gemcitabine—Infection—Doxorubicin—muscle cancer	4.41e-05	0.000605	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	4.41e-05	0.00226	CbGpPWpGaD
Gemcitabine—Pain—Methotrexate—muscle cancer	4.39e-05	0.000602	CcSEcCtD
Gemcitabine—Nervous system disorder—Doxorubicin—muscle cancer	4.36e-05	0.000597	CcSEcCtD
Gemcitabine—Thrombocytopenia—Doxorubicin—muscle cancer	4.35e-05	0.000596	CcSEcCtD
Gemcitabine—Skin disorder—Doxorubicin—muscle cancer	4.32e-05	0.000592	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—BUB1B—muscle cancer	4.3e-05	0.00221	CbGpPWpGaD
Gemcitabine—Hyperhidrosis—Doxorubicin—muscle cancer	4.29e-05	0.000589	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	4.25e-05	0.00218	CbGpPWpGaD
Gemcitabine—Anorexia—Doxorubicin—muscle cancer	4.23e-05	0.000581	CcSEcCtD
Gemcitabine—Feeling abnormal—Methotrexate—muscle cancer	4.23e-05	0.00058	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	4.22e-05	0.00217	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—FH—muscle cancer	4.22e-05	0.00217	CbGpPWpGaD
Gemcitabine—Hypotension—Doxorubicin—muscle cancer	4.15e-05	0.000569	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—BUB1B—muscle cancer	4.12e-05	0.00212	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	4.07e-05	0.00209	CbGpPWpGaD
Gemcitabine—Body temperature increased—Methotrexate—muscle cancer	4.06e-05	0.000556	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	4.05e-05	0.000555	CcSEcCtD
Gemcitabine—RRM1—Metabolism—ENO2—muscle cancer	4.03e-05	0.00207	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	4.02e-05	0.00207	CbGpPWpGaD
Gemcitabine—Insomnia—Doxorubicin—muscle cancer	4.02e-05	0.000551	CcSEcCtD
Gemcitabine—Paraesthesia—Doxorubicin—muscle cancer	3.99e-05	0.000547	CcSEcCtD
Gemcitabine—Dyspnoea—Doxorubicin—muscle cancer	3.96e-05	0.000543	CcSEcCtD
Gemcitabine—Somnolence—Doxorubicin—muscle cancer	3.95e-05	0.000542	CcSEcCtD
Gemcitabine—Decreased appetite—Doxorubicin—muscle cancer	3.86e-05	0.00053	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Doxorubicin—muscle cancer	3.84e-05	0.000526	CcSEcCtD
Gemcitabine—Fatigue—Doxorubicin—muscle cancer	3.83e-05	0.000525	CcSEcCtD
Gemcitabine—Pain—Doxorubicin—muscle cancer	3.8e-05	0.000521	CcSEcCtD
Gemcitabine—Constipation—Doxorubicin—muscle cancer	3.8e-05	0.000521	CcSEcCtD
Gemcitabine—Asthenia—Methotrexate—muscle cancer	3.68e-05	0.000505	CcSEcCtD
Gemcitabine—Feeling abnormal—Doxorubicin—muscle cancer	3.66e-05	0.000502	CcSEcCtD
Gemcitabine—RRM2—Metabolism—MED12—muscle cancer	3.64e-05	0.00187	CbGpPWpGaD
Gemcitabine—Pruritus—Methotrexate—muscle cancer	3.63e-05	0.000498	CcSEcCtD
Gemcitabine—POLD1—Metabolism—MED12—muscle cancer	3.61e-05	0.00186	CbGpPWpGaD
Gemcitabine—Body temperature increased—Doxorubicin—muscle cancer	3.51e-05	0.000482	CcSEcCtD
Gemcitabine—Diarrhoea—Methotrexate—muscle cancer	3.51e-05	0.000481	CcSEcCtD
Gemcitabine—DCK—Metabolism—MED12—muscle cancer	3.4e-05	0.00175	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	3.35e-05	0.00172	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ENO2—muscle cancer	3.32e-05	0.0017	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ENO2—muscle cancer	3.3e-05	0.00169	CbGpPWpGaD
Gemcitabine—Vomiting—Methotrexate—muscle cancer	3.26e-05	0.000447	CcSEcCtD
Gemcitabine—Rash—Methotrexate—muscle cancer	3.23e-05	0.000444	CcSEcCtD
Gemcitabine—Dermatitis—Methotrexate—muscle cancer	3.23e-05	0.000443	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2A—muscle cancer	3.21e-05	0.00165	CbGpPWpGaD
Gemcitabine—Headache—Methotrexate—muscle cancer	3.21e-05	0.000441	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	3.2e-05	0.00165	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2A—muscle cancer	3.2e-05	0.00164	CbGpPWpGaD
Gemcitabine—Asthenia—Doxorubicin—muscle cancer	3.19e-05	0.000437	CcSEcCtD
Gemcitabine—Pruritus—Doxorubicin—muscle cancer	3.14e-05	0.000431	CcSEcCtD
Gemcitabine—DCK—Metabolism—ENO2—muscle cancer	3.1e-05	0.00159	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2A—muscle cancer	3.09e-05	0.00159	CbGpPWpGaD
Gemcitabine—Nausea—Methotrexate—muscle cancer	3.05e-05	0.000418	CcSEcCtD
Gemcitabine—Diarrhoea—Doxorubicin—muscle cancer	3.04e-05	0.000417	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—PTGS2—muscle cancer	2.99e-05	0.00154	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	2.94e-05	0.00151	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2A—muscle cancer	2.87e-05	0.00148	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN2A—muscle cancer	2.86e-05	0.00147	CbGpPWpGaD
Gemcitabine—Vomiting—Doxorubicin—muscle cancer	2.82e-05	0.000387	CcSEcCtD
Gemcitabine—Rash—Doxorubicin—muscle cancer	2.8e-05	0.000384	CcSEcCtD
Gemcitabine—Dermatitis—Doxorubicin—muscle cancer	2.8e-05	0.000384	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—MDM2—muscle cancer	2.79e-05	0.00143	CbGpPWpGaD
Gemcitabine—Headache—Doxorubicin—muscle cancer	2.78e-05	0.000382	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—MDM2—muscle cancer	2.77e-05	0.00142	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2A—muscle cancer	2.76e-05	0.00142	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MDM2—muscle cancer	2.68e-05	0.00138	CbGpPWpGaD
Gemcitabine—Nausea—Doxorubicin—muscle cancer	2.64e-05	0.000362	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.53e-05	0.0013	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.42e-05	0.00124	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—MED12—muscle cancer	2.38e-05	0.00122	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—muscle cancer	2.32e-05	0.00119	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	2.31e-05	0.00119	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2A—muscle cancer	2.2e-05	0.00113	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ENO2—muscle cancer	2.17e-05	0.00112	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—muscle cancer	2.11e-05	0.00108	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—muscle cancer	2e-05	0.00103	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—muscle cancer	1.97e-05	0.00101	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MDM2—muscle cancer	1.91e-05	0.00098	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—muscle cancer	1.88e-05	0.000968	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—muscle cancer	1.85e-05	0.000951	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MDM2—muscle cancer	1.83e-05	0.000939	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—muscle cancer	1.6e-05	0.000822	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—muscle cancer	1.59e-05	0.000817	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—muscle cancer	1.54e-05	0.000789	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—muscle cancer	1.4e-05	0.000721	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	1.3e-05	0.000669	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—FH—muscle cancer	1.3e-05	0.000669	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	1.26e-05	0.000645	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—muscle cancer	1.15e-05	0.000593	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—muscle cancer	1.15e-05	0.00059	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—muscle cancer	1.09e-05	0.000562	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—muscle cancer	1.08e-05	0.000555	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—muscle cancer	1.05e-05	0.000539	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	9.89e-06	0.000508	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—muscle cancer	7.57e-06	0.000389	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	7.47e-06	0.000384	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MED12—muscle cancer	7.35e-06	0.000378	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ENO2—muscle cancer	6.7e-06	0.000344	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—muscle cancer	2.33e-06	0.00012	CbGpPWpGaD
